With 14 years of experience, Mexico Bariatric Center® continues to provide specialized weight-loss care and patient ...

A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

Health coaching focuses on sustained engagement, helping families build habits over time rather than relying on one-time counseling. This approach also incorporates mental health, stress, sleep, and ...

Americans are some of the most overweight people in the world, not just stereotypically but statistically too,” analysts said in the report. Nearly 42% of U.S. adults are cla ...

FDA approval establishes setmelanotide as the first labeled option for acquired hypothalamic obesity, addressing a population ...

A proposed rule first introduced by the USDA in September would expand the range of healthy foods that retailers must stock.

Obesity and loneliness contributed to the morbidity and mortality of COVID-19, but new advances may now address these ...

As use of GLP-1 medications surges, tools like Weight Loss Buddy emerge as critical infrastructure for sustaining ...

Right now, the drugs come with a hefty price tag. Ozempic typically runs 8,800 to 11,000 rupees ($95–$119) per month, while ...

Broad generic availability of semaglutide is not expected until the early 2030s, which means most Americans will stay on branded Ozempic and Wegovy for years to come. Some patients may eye Canadian ...

Eli Lilly's next-generation obesity drug retatrutide helped significantly reduce A1C levels for people with diabetes while helping them lose weight.

Novo Nordisk said the U.S. Food and Drug Administration approved a higher dosage of its Wegovy weight-loss medication, a boost for the Danish drugmaker as it faces growing competition in the obesity ...